cover image - Study Guide for Lehne's Pharmacology for Nursing Care - Elsevier eBook on VitalSource, 12th Edition
ISBN: 9780443106491
Copyright: 2025
Publication Date: 01-18-2024
Page Count: 320
Imprint: Saunders
List Price: $38.99

Study Guide for Lehne's Pharmacology for Nursing Care - Elsevier eBook on VitalSource, 12th Edition

by Jacqueline Rosenjack Burchum, DNSc, FNP-BC, CNE and Laura D. Rosenthal, DNP, RN, ACNP-BC, FAANP

Elsevier eBook on VitalSource

cover image - Study Guide for Lehne's Pharmacology for Nursing Care - Elsevier eBook on VitalSource, 12th Edition
ISBN: 9780443106491
Copyright: 2025
Publication Date: 01-18-2024
Page Count: 320
Imprint: Saunders
List Price: $38.99
Was $38.99

Now $34.31

Or $0.00 with a valid access code
Master nursing pharmacology with this practical study guide that incorporates the latest NCLEX® item types! Corresponding to the chapters in Lehne's Pharmacology for Nursing Care, 12th Edition, this comprehensive workbook provides a thorough review of the most important textbook content. Clinical judgment and study questions help you apply your drug knowledge to nursing care, prioritize tasks, and develop clinical decision-making skills; patient teaching scenarios help you learn effective patient education. With a Case Study for the Next-Generation NCLEX® Exam (NGN) in each unit, this study guide provides an excellent review for the NGN and for safe clinical practice.
    • Reinforcement of key textbook content equips you for success on the Next-Generation NCLEX® Exam (NGN) and for patient safety in clinical practice
    • NCLEX® Examination–style questions in each chapter include multiple-choice, multiple-select, and alternate-item formats, preparing you for success on the NGN and for safe clinical practice
    • Dosage Calculation questions in every clinical chapter provide important practice in applying drug information and providing medication safety
    • Focus on implications of drugs and drug classes on patient care includes activities and questions that are designed for you to answer "How do the drugs work in the body?" and "How do these drug actions impact patient care?"
    • Answer key with rationales is included in the back of the book for immediate feedback and remediation
    • NEW! Updated content ensures that information is consistent with the Lehne's Pharmacology for Nursing Care, 12th Edition textbook, and reflects the latest FDA drug approvals, withdrawals, and therapeutic uses
    • NEW! A standalone case study for the Next-Generation NCLEX® (NGN) is included in every unit
  • UNIT ONE Introduction
    1. Orientation to Pharmacology
    2. Application of Pharmacology in Nursing Practice
    3. Drug Regulation, Development, Names, and Information

    UNIT TWO Basic Principles of Pharmacology
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Drug Interactions
    7. Adverse Drug Reactions and Medication Errors
    8. Individual Variation to Drug Responses
    9. Genetic and Genomic Considerations
    10. Introduction to Immunomodulators

    UNIT THREE Drug Therapy Across the Life Span
    11. Drug Therapy During Pregnancy and Breastfeeding
    12. Drug Therapy in Pediatric Patients
    13. Drug Therapy in Older Adult Patients

    UNIT FOUR Peripheral Nervous System Drugs
    Section 1 Introduction
    14. Basic Principles of Neuropharmacology
    15. Physiology of the Peripheral Nervous System
    Section 2 Cholinergic Drugs
    16. Muscarinic Agonists
    17. Muscarinic Antagonists
    18. Cholinesterase Inhibitors and Their Use in Myasthenia Gravis
    19. Drugs That Block Nicotinic Cholinergic Transmission
    Section 3 Adrenergic Drugs
    20. Adrenergic Agonists
    21. Adrenergic Antagonists
    22. Indirect-Acting Antiadrenergic Agents

    UNIT FIVE Central Nervous System Drugs
    Section 4 Introduction
    23. Introduction to Central Nervous System Pharmacology
    Section 5 Drugs for Neurodegenerative Disorders
    24. Drugs for Parkinson Disease
    25. Drugs for Alzheimer Disease
    26. Drugs for Multiple Sclerosis
    Section 6 Neurologic Drugs
    27. Drugs for Seizure Disorders
    28. Drugs for Muscle Spasm and Spasticity
    Section 7 Drugs for Pain
    29. Local Anesthetics
    30. General Anesthetics
    31. Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics
    32. Pain Management in Patients With Cancer
    33. Drugs for Headache
    Section 8 Psychotherapeutic Drugs
    34. Antipsychotic Agents and Their Use in Schizophrenia
    35. Antidepressants
    36. Drugs for Bipolar Disorder
    37. Sedative-Hypnotic Drugs
    38. Management of Anxiety Disorders
    39. Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder
    Section 9 Substance Use Disorders
    40. Substance Use Disorders I: Basic Considerations
    41. Substance Use Disorders II: Alcohol
    42. Substance Use Disorders III: Nicotine
    43. Substance Use Disorders IV: Major Drugs of Abuse Other Than Alcohol and Nicotine

    UNIT SIX Drugs That Affect Fluid and Electrolyte Balance
    44. Diuretics
    45. Agents Affecting the Volume and Ion Content of Body Fluids

    UNIT SEVEN Drugs That Affect the Heart, Blood Vessels, and Blood
    46. Review of Hemodynamics
    47. Drugs Acting on the Renin-Angiotensin-Aldosterone System
    48. Calcium Channel Blockers
    49. Vasodilators
    50. Drugs for Hypertension
    51. Drugs for Heart Failure
    52. Antidysrhythmic Drugs
    53. Drugs That Help Normalize Cholesterol and Triglyceride Levels
    54. Drugs for Angina Pectoris
    55. Anticoagulant, Antiplatelet, and Thrombolytic Drugs
    56. Management of ST-Elevation Myocardial Infarction
    57. Drugs for Hemophilia
    58. Drugs for Deficiency Anemias
    59. Hematopoietic Agents

    UNIT EIGHT Drugs for Endocrine Disorders
    60. Drugs for Diabetes Mellitus
    61. Drugs for Thyroid Disorders
    62. Drugs Related to Hypothalamic and Pituitary Function
    63. Drugs for Disorders of the Adrenal Cortex

    UNIT NINE Reproductive Health
    64. Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications
    65. Birth Control
    66. Drug Therapy for Infertility
    67. Drugs That Affect Uterine Function
    68. Androgens
    69. Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
    70. Transgender Health

    UNIT TEN Anti-inflammatory, Antiallergic, and Immunologic Drugs
    71. Review of the Immune System
    72. Childhood Immunization
    73. Immunosuppressants
    74. Antihistamines
    75. Cyclooxygenase Inhibitors: Nonsteroidal Antiinflammatory Drugs and Acetaminophen
    76. Glucocorticoids in Nonendocrine Disorders

    UNIT ELEVEN Drugs for Bone and Joint Disorders
    77. Drug Therapy for Rheumatoid Arthritis
    78. Drug Therapy for Gout
    79. Drugs Affecting Calcium Levels and Bone Mineralization

    UNIT TWELVE Respiratory Tract Drugs
    80. Drugs for Asthma and Chronic Obstructive Pulmonary Disease
    81. Drugs for Allergic Rhinitis, Cough, and Colds

    UNIT THIRTEEN Gastrointestinal Drugs
    82. Drugs for Peptic Ulcer Disease
    83. Laxatives
    84. Other Gastrointestinal Drugs

    UNIT FOURTEEN Nutrition and Complementary Therapy
    85. Vitamins
    86. Drugs for Weight Loss
    87. Complementary and Alternative Therapy

    UNIT FIFTEEN Therapy of Infectious Diseases
    88. Basic Principles of Antimicrobial Therapy
    89. Drugs That Weaken the Bacterial Cell Wall I: Penicillins
    90. Drugs That Weaken the Bacterial Cell Wall II: Other Drugs
    91. Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others
    92. Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis
    93. Sulfonamide Antibiotics and Trimethoprim
    94. Drug Therapy for Urinary Tract Infections
    95. Antimycobacterial Agents: Drugs for Tuberculosis
    96. Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole, Daptomycin, Rifampin, Rifaximin, and Fidaxomicin
    97. Antifungal Agents
    98. Antiviral Agents I: Drugs for Non-HIV Viral Infections
    99. Antiviral Agents II: Drugs for HIV Infection and Related Opportunistic Infections
    100. Drug Therapy for Sexually Transmitted Infections
    101. Antiseptics and Disinfectants

    UNIT SIXTEEN Chemotherapy of Parasitic Diseases
    102. Anthelmintics
    103. Antiprotozoal Drugs I: Antimalarial Agents
    104. Antiprotozoal Drugs II: Miscellaneous Agents
    105. Ectoparasiticides

    UNIT SEVENTEEN Cancer Chemotherapy
    106. Basic Principles of Cancer Chemotherapy
    107. Anticancer Drugs I: Cytotoxic Agents
    108. Anticancer Drugs II: Hormonal Agents, Targeted Drugs, and Other Noncytotoxic Anticancer Drugs

    UNIT EIGHTEEN Miscellaneous Drugs and Therapies
    109. Drugs for Eye Conditions and Diseases
    110. Drugs for Skin Conditions
    111. Drugs for Ear Conditions

    UNIT NINETEEN Toxicology
    112. Management of Poisoning
    113. Potential Weapons of Biologic, Radiologic, and Chemical Terrorism

    Answer Key
  • Jacqueline Rosenjack Burchum, DNSc, FNP-BC, CNE, Associate Professor, College of Nursing, Department of Advanced Practice and Doctoral Studies, University of Tennessee Health Science Center, Memphis, Tennessee, USA and Laura D. Rosenthal, DNP, RN, ACNP-BC, FAANP, Professor, College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
      • Has alternative text descriptions for images
    • Conformance
    • Navigation
      • Table of contents to all chapters of the text via links
      • Elements such as headings, tables, etc. for structured navigation
      • Page list to go to pages from the print source version
    • Rich Content
      • Information-rich images are described by extended descriptions
    • Hazards
      • The publication contains no hazards
    • Product Content
      • The primary content is text.
      • Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
      • Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, 'choose your own ending', etc.).
      • Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Content provides explanations for unusual words, abbreviations, acronyms, idioms, jargon in an accessible form, such as glossaries, scripted pop-ups.
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $38.99

Now $34.31

Or $0.00 with a valid access code